Rocket Pharmaceuticals In... (RCKT)
NASDAQ: RCKT
· Real-Time Price · USD
3.23
-0.09 (-2.71%)
At close: Sep 04, 2025, 3:59 PM
3.24
0.16%
Pre-market: Sep 05, 2025, 09:21 AM EDT
-2.71% (1D)
| Bid | 2.76 |
| Market Cap | 348.53M |
| Revenue (ttm) | 9.19M |
| Net Income (ttm) | -257.3M |
| EPS (ttm) | -2.51 |
| PE Ratio (ttm) | -1.29 |
| Forward PE | -2.74 |
| Analyst | Buy |
| Ask | 3.63 |
| Volume | 1,597,752 |
| Avg. Volume (20D) | 4,415,014 |
| Open | 3.31 |
| Previous Close | 3.32 |
| Day's Range | 3.17 - 3.31 |
| 52-Week Range | 2.19 - 22.01 |
| Beta | 0.65 |
About RCKT
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol RCKT
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for RCKT stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock ForecastsNext Earnings Release
Rocket Pharmaceuticals Inc. is scheduled to release its earnings on
Nov 6, 2025,
during market hours.
Analysts project revenue of ... Unlock content with Pro Subscription
Analysts project revenue of ... Unlock content with Pro Subscription
2 weeks ago
+28.87%
Rocket Pharmaceuticals shares are trading higher a...
Unlock content with
Pro Subscription
1 month ago
+4.32%
Shares of several biotechnology stocks are trading higher amid Vinay Prasad's departure as director of the FDA's Center for Biologics Evaluation and Research.
